CancerNetwork®’s podcast dissected a review article published in the journal ONCOLOGY® on the 21-gene recurrence score in patients with node-positive breast cancer.
This week, CancerNetwork® examined a review article published in the February issue of the Journal ONCOLOGY titled “Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.”
The piece highlights the existing literature regarding the prognostic and predictive capabilities of the Oncotype Dx 21-gene recurrence score in patients with node-positive breast cancer, focusing on current practice patterns and emerging applications from the surrounding literature.
For the summary, CancerNetwork® spoke with 2 authors of the review, Alison Laws, MD, an associate surgeon at the Brigham and Women’s Hospital, and Philip Poorvu, MD, a medical oncologist at the Dana-Farber Cancer Institute. Laws and Poorvu provided…
